• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.沿着反应中心环的单个荧光探针揭示了纤溶酶原激活物抑制剂-1潜伏转变过程中的位点特异性变化。
Protein Sci. 2016 Feb;25(2):487-98. doi: 10.1002/pro.2839. Epub 2015 Nov 25.
2
Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.活性中心环构象和动力学变化揭示了纤溶酶原激活物抑制剂-1(PAI-1)与纤溶酶原激活物及玻连蛋白形成的不同结合复合物。
Protein Sci. 2016 Feb;25(2):499-510. doi: 10.1002/pro.2841. Epub 2015 Dec 2.
3
Specific interactions of serpins in their native forms attenuate their conformational transitions.丝氨酸蛋白酶抑制剂(serpins)天然形式下的特异性相互作用会减弱其构象转变。
Protein Sci. 2007 Aug;16(8):1659-66. doi: 10.1110/ps.072838107. Epub 2007 Jun 28.
4
Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy.通过时间分辨荧光各向异性探测纤溶酶原激活物抑制剂-1的纳秒级运动。
Mol Biosyst. 2009 Sep;5(9):1025-31. doi: 10.1039/b901691k. Epub 2009 May 7.
5
Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.噬菌体展示的高突变纤溶酶原激活物抑制剂1(PAI-1)文库证明,潜伏期转变和蛋白酶抑制过程中PAI-1的不同结构要求。
J Mol Biol. 2001 Jan 26;305(4):773-83. doi: 10.1006/jmbi.2000.4356.
6
RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.RNA 适体作为纤维蛋白溶酶原激活物抑制剂-1 的构象探针和调节因子。
Biochemistry. 2010 May 18;49(19):4103-15. doi: 10.1021/bi100066j.
7
The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.活性纤溶酶原激活物抑制剂-1的反应中心环折叠靠近蛋白质核心,且可部分插入。
J Mol Biol. 2004 Jan 16;335(3):823-32. doi: 10.1016/j.jmb.2003.11.005.
8
Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C.具有分离的β链1C的丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1潜伏前体形式的证据。
J Biol Chem. 2006 Nov 24;281(47):36071-81. doi: 10.1074/jbc.M606851200. Epub 2006 Oct 3.
9
Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved.纤溶酶原激活物抑制剂 1 的潜伏期转移是进化保守的。
Thromb Haemost. 2017 Aug 30;117(9):1688-1699. doi: 10.1160/TH17-02-0102. Epub 2017 Aug 3.
10
Protein conformational change delayed by steric hindrance from an N-linked glycan.N-连接聚糖的空间位阻延迟蛋白质构象变化。
J Mol Biol. 2013 Aug 23;425(16):2867-77. doi: 10.1016/j.jmb.2013.05.007. Epub 2013 May 20.

本文引用的文献

1
Serpin latency transition at atomic resolution.丝氨酸蛋白酶抑制剂在原子分辨率下的潜伏态转变。
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15414-9. doi: 10.1073/pnas.1407528111. Epub 2014 Oct 13.
2
Local transient unfolding of native state PAI-1 associated with serpin metastability.局部瞬时展开天然状态 PAI-1 与丝氨酸蛋白酶抑制剂的不稳定性相关。
Angew Chem Int Ed Engl. 2014 Sep 8;53(37):9751-4. doi: 10.1002/anie.201402796. Epub 2014 Jul 22.
3
Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry.利用氢/氘交换质谱法解析 RNA 适体结合对纤溶酶原激活物抑制剂 1 动力学的影响。
ACS Chem Biol. 2014 Jan 17;9(1):174-82. doi: 10.1021/cb400619v. Epub 2013 Nov 14.
4
Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).纤溶酶原激活物抑制剂-1 抑制剂:专利研究综述(2006 年至今)。
Expert Opin Ther Pat. 2013 Jul;23(7):801-15. doi: 10.1517/13543776.2013.782393. Epub 2013 Mar 25.
5
A peptide mimicking the C-terminal part of the reactive center loop induces the transition to the latent form of plasminogen activator inhibitor type-1.一段模拟反应中心环 C 末端部分的肽诱导纤溶酶原激活物抑制剂-1 向潜伏形式的转变。
FEBS Lett. 2012 Mar 23;586(6):686-92. doi: 10.1016/j.febslet.2012.02.013. Epub 2012 Feb 17.
6
Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability.纤溶酶原激活物抑制剂-1 处于活性构象及具有正常热力学稳定性的晶体结构。
J Biol Chem. 2011 Aug 26;286(34):29709-17. doi: 10.1074/jbc.M111.236554. Epub 2011 Jun 21.
7
Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.金属会影响人纤溶酶原激活物抑制剂-1 的结构和活性。二。结合亲和力和构象变化。
Protein Sci. 2011 Feb;20(2):366-78. doi: 10.1002/pro.567.
8
Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.金属影响人纤溶酶原激活物抑制剂-1 的结构和活性。I. 稳定性和蛋白酶抑制的调节。
Protein Sci. 2011 Feb;20(2):353-65. doi: 10.1002/pro.568.
9
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.尿激酶型纤溶酶原激活物与其抑制剂-1 识别的结构基础。
J Biol Chem. 2011 Mar 4;286(9):7027-32. doi: 10.1074/jbc.M110.204537. Epub 2011 Jan 3.
10
Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy.通过时间分辨荧光各向异性探测纤溶酶原激活物抑制剂-1的纳秒级运动。
Mol Biosyst. 2009 Sep;5(9):1025-31. doi: 10.1039/b901691k. Epub 2009 May 7.

沿着反应中心环的单个荧光探针揭示了纤溶酶原激活物抑制剂-1潜伏转变过程中的位点特异性变化。

Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.

作者信息

Qureshi Tihami, Peterson Cynthia B

机构信息

Department of Biochemistry, Cellular and Molecular Biology, University of Tennessee, Knoxville, Tennessee, 37996.

出版信息

Protein Sci. 2016 Feb;25(2):487-98. doi: 10.1002/pro.2839. Epub 2015 Nov 25.

DOI:10.1002/pro.2839
PMID:26540464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4815349/
Abstract

The serine protease inhibitor (serpin), plasminogen activator inhibitor-1 (PAI-1), is an important biomarker for cardiovascular disease and many cancers. It is therefore a desirable target for pharmaceutical intervention. However, to date, no PAI-1 inhibitor has successfully reached clinical trial, indicating the necessity to learn more about the mechanics of the serpin. Although its kinetics of inhibition have been extensively studied, less is known about the latency transition of PAI-1, in which the solvent-exposed reactive center loop (RCL) inserts into its central β-sheet, rendering the inhibitor inactive. This spontaneous transition is concomitant with a large translocation of the RCL, but no change in covalent structure. Here, we conjugated the fluorescent probe, NBD, to single positions along the RCL (P13-P5') to detect changes in solvent exposure that occur during the latency transition. The results support a mousetrap-like RCL-insertion that occurs with a half-life of 1-2 h in accordance with previous reports. Importantly, this study exposes unique transitions during latency that occur with a half-life of ∼5 and 25 min at the P5' and P8 RCL positions, respectively. We hypothesize that the process detected at P5' represents s1C detachment, while that at P8 results from a steric barrier to RCL insertion. Together, these findings provide new insights by characterizing multiple steps in the latency transition.

摘要

丝氨酸蛋白酶抑制剂(serpin),纤溶酶原激活物抑制剂-1(PAI-1),是心血管疾病和许多癌症的重要生物标志物。因此,它是药物干预的理想靶点。然而,迄今为止,尚无PAI-1抑制剂成功进入临床试验,这表明有必要更多地了解serpin的作用机制。尽管其抑制动力学已得到广泛研究,但对于PAI-1的潜伏转变了解较少,在潜伏转变过程中,暴露于溶剂中的反应中心环(RCL)插入其中心β-折叠,使抑制剂失活。这种自发转变伴随着RCL的大量移位,但共价结构没有变化。在这里,我们将荧光探针NBD连接到RCL(P13-P5')沿线的单个位置,以检测潜伏转变过程中发生的溶剂暴露变化。结果支持了一种类似捕鼠器的RCL插入,其半衰期为1-2小时,与先前的报道一致。重要的是,这项研究揭示了潜伏期间独特的转变,分别在P5'和P8 RCL位置以约5分钟和25分钟的半衰期发生。我们假设在P5'处检测到的过程代表s1C分离,而在P8处的过程是由于RCL插入的空间位垒。总之,这些发现通过表征潜伏转变中的多个步骤提供了新的见解。